RIL
HRTX icon

Rothschild Investment LLC’s Heron Therapeutics HRTX Stock Holding History

Rothschild Investment LLC’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221 Buy
518
+269
+108% +$216 ﹤0.01% 3427
2026
Q1 		$199 Buy
249
+194
+353% +$225 ﹤0.01% 3305
2025
Q4 		$72 Buy
55
+23
+72% +$28 ﹤0.01% 3244
2025
Q3 		$40 Sell
32
-203
-86% -$322 ﹤0.01% 3098
2025
Q2 		$486 Buy
+235
New +$480 ﹤0.01% 2755
2024
Q3 		– Sell
-85
Closed -$298 – 2937
2024
Q2 		$298 Buy
+85
New +$261 ﹤0.01% 2303

Other funds holding HRTX

CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AR
Apeiron RIA Dallas, Texas $390M AUM 22.97% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
RFW
Redwood Family Wealth Addison, Texas $114M AUM

Rothschild Investment LLC's HRTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Heron Therapeutics (HRTX) stake by 108% in Q2 2026, buying an estimated $216 and bringing the position to 518 shares worth $221. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

Rothschild Investment LLC first reported a position in HRTX in Q2 2024 and has held it in 6 quarters since. The position peaked at $486 in Q2 2025. 58 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Rothschild Investment LLC held 518 shares of Heron Therapeutics worth $221 as of Q2 2026.
  • Rothschild Investment LLC bought 269 Heron Therapeutics shares in Q2 2026, an estimated $216.
  • Heron Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3427 holding.
  • Rothschild Investment LLC first reported a position in Heron Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Rothschild Investment LLC's Heron Therapeutics position peaked at $486 in Q2 2025.
  • 58 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.